Literature DB >> 19337014

Cardiovascular autonomic function in Cushing's syndrome.

F Fallo1, P Maffei, A Dalla Pozza, M Carli, P Della Mea, M Lupia, F Rabbia, N Sonino.   

Abstract

Cardiac autonomic dysfunction is associated with increased cardiovascular mortality. No data on sympathovagal balance are available in patients with Cushing's syndrome, in whom cardiovascular risk is high. We studied 10 patients with newly diagnosed Cushing's syndrome (1 male/9 females; age mean+/-SD, 47+/-10 yr) and 10 control subjects matched for age, sex, body mass index, and cardiovascular risk factors. In both groups there were 7 patients with arterial hypertension, 3 with diabetes mellitus, and 2 with obesity. Cardiac autonomic function was evaluated by analysis of short time heart rate variability (HRV) measures in frequency domain over 24-h, daytime, and nighttime. The 24-h ambulatory blood pressure monitoring and echocardiography were also performed. In comparison with controls, patients with Cushing's syndrome had lower 24-h (1.3+/-0.6 vs 3.7+/-1.5, mean+/-SD, p<0.01), daytime (2.0+/-1.4 vs 4.5+/-1.6, p<0.01), and night-time (1.0+/-0.4 vs 3.5+/-2.3, p<0.01) low-frequency/ high frequency (LF/HF) power ratio. In the presence of similar LF power, the difference was due to elevation in HF power in Cushing's syndrome compared to controls: 24-h, 12.7+/-6.7 vs 5.8+/-2.8, p<0.01; daytime, 10.2+/-7.3 vs 4.5+/-2.1, p<0.05; nighttime, 14.2+/-7.0 vs 7.8+/-4.7, p<0.05. Eight Cushing patients vs 4 controls had a non-dipping blood pressure profile. At echocardiography, Cushing patients had a greater left ventricular mass index and/or relative wall thickness, and impaired diastolic function, compared with controls. Compared to controls, patients with Cushing's syndrome showed a sympathovagal imbalance, characterized by a relatively increased parasympathetic activity. Whether this autonomic alteration is meant to counterbalance cortisol-induced effects on blood pressure and cardiac structure/function or has a different pathophysiological significance is still unknown.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337014     DOI: 10.1007/bf03345677

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  40 in total

Review 1.  Cushing's syndrome.

Authors:  M Boscaro; L Barzon; F Fallo; N Sonino
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

2.  Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity.

Authors:  Paolo Palatini; Daniele Longo; Vania Zaetta; Davor Perkovic; Raffaella Garbelotto; Achille C Pessina
Journal:  J Hypertens       Date:  2006-07       Impact factor: 4.844

Review 3.  Glucocorticoids and cardiovascular disease.

Authors:  Brian R Walker
Journal:  Eur J Endocrinol       Date:  2007-11       Impact factor: 6.664

4.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

5.  Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus.

Authors:  A J Burger; M Charlamb; H B Sherman
Journal:  Int J Cardiol       Date:  1999-09-30       Impact factor: 4.164

Review 6.  Glucocorticoid-induced hypertension: from mouse to man.

Authors:  J A Whitworth; C G Schyvens; Y Zhang; G J Mangos; J J Kelly
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-12       Impact factor: 2.557

7.  Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study.

Authors:  Hirohito Metoki; Takayoshi Ohkubo; Masahiro Kikuya; Kei Asayama; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

8.  Sympathovagal imbalance in acromegalic patients.

Authors:  Eugenia Resmini; Massimo Casu; Vittoriana Patrone; Giovanni Murialdo; Federico Bianchi; Massimo Giusti; Diego Ferone; Francesco Minuto
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

9.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

10.  Measurement of parasympathetic activity from 24-hour ambulatory electrocardiograms and its reproducibility and sensitivity in normal subjects, patients with symptomatic myocardial ischemia, and patients with diabetes mellitus.

Authors:  J Nolan; A D Flapan; N E Goodfield; R J Prescott; P Bloomfield; J M Neilson; D J Ewing
Journal:  Am J Cardiol       Date:  1996-01-15       Impact factor: 2.778

View more
  10 in total

1.  Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.

Authors:  A Comunello; F Dassie; C Martini; E De Carlo; R Mioni; M Battocchio; A Paoletta; F Fallo; R Vettor; P Maffei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

3.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome.

Authors:  Andrea Rebellato; Andrea Grillo; Francesca Dassie; Nicoletta Sonino; Pietro Maffei; Chiara Martini; Agostino Paoletta; Bruno Fabris; Renzo Carretta; Francesco Fallo
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

Review 4.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

5.  Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice.

Authors:  Qing-Qing Zhang; Guo-Qing Li; Yi Zhong; Jie Wang; An-Ning Wang; Xiao Zhou; Xiao-Ming Mao
Journal:  Ther Adv Chronic Dis       Date:  2020-11-25       Impact factor: 5.091

6.  Coronary microvascular function in patients with Cushing's syndrome.

Authors:  Francesco Fallo; Giulia Famoso; Dario Capizzi; Nicoletta Sonino; Francesca Dassie; Pietro Maffei; Chiara Martini; Agostino Paoletta; Sabino Iliceto; Francesco Tona
Journal:  Endocrine       Date:  2012-08-01       Impact factor: 3.633

Review 7.  The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Authors:  Andrea M Isidori; Chiara Graziadio; Rosa Maria Paragliola; Alessia Cozzolino; Alberto G Ambrogio; Annamaria Colao; Salvatore M Corsello; Rosario Pivonello
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

8.  Cushing's Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography.

Authors:  Agnieszka Jurek; Paweł Krzesiński; Grzegorz Gielerak; Przemysław Witek; Grzegorz Zieliński; Anna Kazimierczak; Robert Wierzbowski; Małgorzata Banak; Beata Uziębło-Życzkowska
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-01       Impact factor: 5.555

9.  Blood Pressure and Left Ventricular Characteristics in Young Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  Graziamaria Ubertini; Carla Bizzarri; Armando Grossi; Fabrizio Gimigliano; Lucilla Ravà; Danilo Fintini; Marco Cappa
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-07

10.  Cushing's Disease Presented by Reversible Dilated Cardiomyopathy.

Authors:  Berna İmge Aydoğan; Demet Menekşe Gerede; Asena Gökçay Canpolat; Murat Faik Erdoğan
Journal:  Case Rep Cardiol       Date:  2015-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.